MRK - Merck & Co., Inc.
89.5
0.620 0.693%
Share volume: 15,678,892
Last Updated: Fri 21 Feb 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.42%
PREVIOUS CLOSE
CHG
CHG%
$88.88
1.82
0.02%
View ratios
| Fiscal Date | 2023-09-30 | 2023-09-30 | 2023-12-31 | 2023-12-31 | 2024-03-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2023 | Q3 2023 | Q4 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-11-03 | 2023-11-03 | 2024-11-06 | 2024-02-26 | 2024-05-03 | 2024-05-03 | 2024-08-05 | 2024-11-06 | |
| Assets | |||||||||
| Total Assets | 106.727 B | 106.727 B | 106.675 B | 106.675 B | 105.849 B | 105.849 B | 112.630 B | 117.532 B | |
| Current Assets | 31.954 B | 31.954 B | 32.168 B | 32.168 B | 31.445 B | 31.445 B | 38.205 B | 40.361 B | |
| Inventories | 6.131 B | 6.131 B | 6.358 B | 6.358 B | 6.510 B | 6.510 B | 6.469 B | 6.244 B | |
| Other Current Assets | 6.656 B | 6.656 B | 8.368 B | 8.368 B | 7.950 B | 7.950 B | 8.740 B | 8.143 B | |
| Short Term Investments | 168.000 M | 6.656 B | 252.000 M | 8.368 B | 40.000 M | 7.950 B | 50.000 M | 0.000 | |
| Total Receivables | 0.000 | 10.394 B | 0.000 | 10.349 B | 0.000 | 11.366 B | 0.000 | 0.000 | |
| Current Cash | 8.605 B | 8.773 B | 6.841 B | 7.093 B | 5.579 B | 5.619 B | 11.304 B | 14.593 B | |
| Total Non-current Assets | 1.306 B | 74.773 B | 252.000 M | 74.507 B | 280.000 M | 74.404 B | 357.000 M | 575.000 M | |
| Property Plant Equipment | 22.526 B | 22.526 B | 23.051 B | 23.051 B | 23.045 B | 23.045 B | 23.221 B | 23.446 B | |
| Other Assets | 52.247 B | 10.559 B | 51.456 B | 11.996 B | 51.359 B | 12.326 B | 51.204 B | 53.725 B | |
| Intangible Assets | 0.000 | 19.199 B | 0.000 | 18.011 B | 0.000 | 17.572 B | 0.000 | 0.000 | |
| Goodwill | 0.000 | 21.183 B | 0.000 | 21.197 B | 0.000 | 21.181 B | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 106.727 B | 106.727 B | 106.675 B | 106.675 B | 105.849 B | 105.849 B | 112.630 B | 117.532 B | |
| Total liabilities | 65.427 B | 65.481 B | 69.040 B | 69.094 B | 65.425 B | 65.485 B | 68.982 B | 72.972 B | |
| Total current liabilities | 23.094 B | 23.094 B | 25.694 B | 25.694 B | 25.099 B | 25.099 B | 26.060 B | 29.586 B | |
| Accounts Payable | 3.509 B | 3.509 B | 3.922 B | 3.922 B | 3.514 B | 3.514 B | 3.519 B | 3.586 B | |
| Other liabilities | 7.343 B | 7.343 B | 8.792 B | 8.792 B | 8.262 B | 8.262 B | 7.329 B | 7.540 B | |
| Current long term debt | 0.000 | 887.000 M | 0.000 | 1.372 B | 0.000 | 3.077 B | 0.000 | 0.000 | |
| Long term debt | 33.972 B | 33.972 B | 33.683 B | 33.683 B | 31.142 B | 31.142 B | 34.717 B | 34.982 B | |
| Other liabilities | 7.343 B | 7.343 B | 8.792 B | 8.792 B | 8.262 B | 8.262 B | 7.329 B | 7.540 B | |
| Minority interest | 0.000 | 54.000 M | 0.000 | 54.000 M | 0.000 | 60.000 M | 0.000 | 0.000 | |
| Total Shareholder equity | 41.246 B | 41.246 B | 37.581 B | 37.581 B | 40.364 B | 40.364 B | 43.582 B | 44.502 B | |
| Common stock | 46.146 B | 2.537 B | 46.297 B | 2.534 B | 46.386 B | 2.533 B | 46.150 B | 46.318 B | |
| Retained earnings | 57.082 B | 57.082 B | 53.895 B | 53.895 B | 56.697 B | 56.697 B | 60.187 B | 61.384 B |